KCT0003661尚未招募未知
A 12-week, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of high temperature processed green tea extract on improvement of memory function
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 40(Year) 至 65(Year)(—)
- 性别
- All
入选标准
- •Those who are between the ages of 40 and 65 at the time of screening
- •- Those who complain subjective memory impairment (who answer yes at least 1 question at Subjective Memory Complaints Questionnaire[SMCQ], or score 2 at Global Deterioration Scale[GDS], and score 26 or more at Mini-Mental State Examination in the Korean version of the CERAD assessment packet[MMSE-KC])
排除标准
- •- Diagnosed with any axis 1 psychiatric disorders (depressive disorder, bipolar disorder, generalized anxiety disorder, substance-related disorder) evaluated with a structured instrument
- •- Diagnosed with any major medical or neurological disorders assessed during medical history taking, physical examination or experimental tests
- •- Neuropsychological tests indicate a suspected diagnosis of dementia
- •- A history of traumatic brain injury with loss of consciousness or convulsion
- •- Had taken psychotropic drugs within the past 1 month before screening
- •- Had taken a dietary supplement for improving memory and cognitive skills within the past 1 month before screening
- •- Had taken a dietary supplement made of green tea extract within the past 1 month before screening, or had consumed more than 4 cups of green tea a day
- •- Had experienced allergic reaction with ingredient including green tea
- •- Planning for pregnancy during the period of study participation, currently pregnant or breastfeeding
- •- Participated in another clinical trial within the past 1 months before screening
- •- Any contraindications to MRI (i.e., claustrophobia, metallic foreign devices in the body)
研究者
相似试验
已完成
不适用
A 12-week, randomized, double-blind, placebo-controlled human trial to evaluate of Amomum villosum extract and Atractylodes macrocephala-extract mixture on decrease of body fatKCT0006779Wonkwang University. Iksan Korean Medicine Hospital120
招募中
不适用
Human trial study to evaluate the efficacy and safety of TZ-HVP on decrement of body fatKCT0005883Teazen100
已完成
不适用
A 12-week, randomized, double-blind, placebo-controlled human trial of Chitooligosaccharide(GO2KA1) on decrease of body fatKCT0006015Wonkwang University. Iksan Korean Medicine Hospital80
进行中(未招募)
不适用
A 12-week, randomized, double-blind, placebo-controlled, parallel group, multicenter study to evaluate the efficacy, safety and tolerability of darifenacin (7.5 mg o.d. with voluntary up-titration to 15 mg o.d.) in patients aged = 65 years with overactive bladder - Not applicableOveractive bladder (OAB)EUCTR2004-002894-21-HUovartis Pharma Services AG399
招募中
不适用
A 12-week, randomized, double-blind, placebo-controlled human application trial to evaluate the efficacy and safety of ACP_01 on skin wrinkle improvement and moisturizingKCT0007720Daehan Chemtech Co., Ltd100
